| 1 |
35595151 | Intracellular distribution of vinclozolin and its metabolites differently affects 5α-dihydrotestosterone (DHT)-induced PSA secretion in LNCaP cells. | 2022 May 17 |
4 |
| 2 |
34129879 | Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen. | 2021 Sep 15 |
1 |
| 3 |
24928827 | Inhibition of the DHT-induced PSA secretion by Verbascum xanthophoeniceum and Serenoa repens extracts in human LNCaP prostate epithelial cells. | 2014 Aug 8 |
4 |
| 4 |
21656835 | Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth. | 2012 Feb |
1 |
| 5 |
22154085 | Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. | 2012 Mar |
1 |
| 6 |
20107586 | Molecular and biochemical effects of a kola nut extract on androgen receptor-mediated pathways. | 2009 |
1 |
| 7 |
18500220 | [Dutasteride in the treatment of hormone refractory prostate cancer]. | 2008 Jun |
1 |
| 8 |
17879940 | 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals. | 2007 Dec 1 |
1 |
| 9 |
15176046 | Endothelin A receptor blockade does not alter PSA secretion in prostate cancer cell lines. | 2004 Aug 1 |
1 |
| 10 |
10484069 | Synergistic effect of estramustine and [3'-keto-Bmtl]-[Val2]-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cells. | 1999 Oct 1 |
1 |